Free Trial

Encompass Health (EHC) Stock Price, News & Analysis

Encompass Health logo
$100.75 -0.39 (-0.39%)
Closing price 03/28/2025 03:59 PM Eastern
Extended Trading
$100.33 -0.42 (-0.42%)
As of 03/28/2025 04:20 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Encompass Health Stock (NYSE:EHC)

Key Stats

Today's Range
$100.06
$101.80
50-Day Range
$93.57
$102.31
52-Week Range
$78.53
$104.55
Volume
457,600 shs
Average Volume
649,885 shs
Market Capitalization
$10.15 billion
P/E Ratio
22.59
Dividend Yield
0.67%
Price Target
$107.67
Consensus Rating
Buy

Company Overview

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama.

Remove Ads

Encompass Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
87th Percentile Overall Score

EHC MarketRank™: 

Encompass Health scored higher than 87% of companies evaluated by MarketBeat, and ranked 108th out of 938 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Encompass Health has received a consensus rating of Buy. The company's average rating score is 3.18, and is based on 9 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Encompass Health has only been the subject of 4 research reports in the past 90 days.

  • Read more about Encompass Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Encompass Health are expected to grow by 10.00% in the coming year, from $4.80 to $5.28 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Encompass Health is 22.59, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.55.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Encompass Health is 22.59, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.33.

  • Price to Earnings Growth Ratio

    Encompass Health has a PEG Ratio of 2.31. PEG Ratios above 1 indicate that a company could be overvalued.

  • Price to Book Value per Share Ratio

    Encompass Health has a P/B Ratio of 3.63. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about Encompass Health's valuation and earnings.
  • Percentage of Shares Shorted

    2.10% of the float of Encompass Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Encompass Health has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Encompass Health has recently decreased by 1.42%, indicating that investor sentiment is improving.
  • Dividend Yield

    Encompass Health has a dividend yield of 0.69%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Encompass Health does not have a long track record of dividend growth.

  • Dividend Coverage

    The dividend payout ratio of Encompass Health is 15.25%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Encompass Health will have a dividend payout ratio of 12.88% next year. This indicates that Encompass Health will be able to sustain or increase its dividend.

  • Read more about Encompass Health's dividend.
  • Percentage of Shares Shorted

    2.10% of the float of Encompass Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Encompass Health has a short interest ratio ("days to cover") of 3.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Encompass Health has recently decreased by 1.42%, indicating that investor sentiment is improving.
  • News Sentiment

    Encompass Health has a news sentiment score of 1.68. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.79 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 14 news articles for Encompass Health this week, compared to 7 articles on an average week.
  • Search Interest

    Only 5 people have searched for EHC on MarketBeat in the last 30 days. This is a decrease of -17% compared to the previous 30 days.
  • MarketBeat Follows

    Only 7 people have added Encompass Health to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Encompass Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $495,578.00 in company stock.

  • Percentage Held by Insiders

    Only 2.10% of the stock of Encompass Health is held by insiders.

  • Percentage Held by Institutions

    97.25% of the stock of Encompass Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Encompass Health's insider trading history.
Receive EHC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Encompass Health and its competitors with MarketBeat's FREE daily newsletter.

EHC Stock News Headlines

Musk’s real agenda in D.C.
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…
Encompass Health Declares Dividend on Common Stock
Encompass Health (EHC) Gets a Buy from Truist Financial
See More Headlines

EHC Stock Analysis - Frequently Asked Questions

Encompass Health's stock was trading at $92.35 at the beginning of 2025. Since then, EHC stock has increased by 9.1% and is now trading at $100.7490.
View the best growth stocks for 2025 here
.

Encompass Health Co. (NYSE:EHC) issued its earnings results on Thursday, February, 6th. The company reported $1.17 EPS for the quarter, beating the consensus estimate of $1.05 by $0.12. Encompass Health had a trailing twelve-month return on equity of 17.56% and a net margin of 8.48%.

Encompass Health's board initiated a stock buyback program on Wednesday, July 24th 2024, which allows the company to buy back $500,000,000 in outstanding shares, according to EventVestor. This means that the company could reacquire up to 5.4% of its shares through open market purchases. Shares buyback programs are often a sign that the company's leadership believes its stock is undervalued.

Encompass Health subsidiaries include Baptist Outpatient Services Inc., Frontier Home Health and Hospice, Generation Solutions of Lynchburg LLC, Alacare Home Health & Hospice, Camellia Healthcare, CareSouth Health System Inc., Reliant Hospital Partners LLC, and others.

Top institutional shareholders of Encompass Health include Vanguard Group Inc. (10.33%), Invesco Ltd. (5.50%), Wellington Management Group LLP (4.00%) and Alliancebernstein L.P. (2.06%). Insiders that own company stock include Mark J Tarr, Douglas E Coltharp, John Patrick Darby, Andrew L Price, Elissa Joy Charbonneau, Greg D Carmichael and Kevin J O'connor.
View institutional ownership trends
.

Shares of EHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Encompass Health investors own include NVIDIA (NVDA), Meta Platforms (META), Broadcom (AVGO), Advanced Micro Devices (AMD), Adobe (ADBE), ServiceNow (NOW) and Arista Networks (ANET).

Company Calendar

Record date for 1/15 Dividend
1/02/2025
Ex-Dividend for 1/15 Dividend
1/02/2025
Dividend Payable
1/15/2025
Last Earnings
2/06/2025
Today
3/29/2025
Record date for 4/15 Dividend
4/01/2025
Ex-Dividend for 4/15 Dividend
4/01/2025
Dividend Payable
4/15/2025
Next Earnings (Estimated)
4/23/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Hospitals
Sub-Industry
Health Care Facilities
Current Symbol
NYSE:EHC
Employees
35,000
Year Founded
1984

Price Target and Rating

Average Stock Price Target
$107.67
High Stock Price Target
$120.00
Low Stock Price Target
$95.00
Potential Upside/Downside
+6.9%
Consensus Rating
Buy
Rating Score (0-4)
3.18
Research Coverage
11 Analysts

Profitability

Trailing P/E Ratio
22.59
Forward P/E Ratio
20.99
P/E Growth
2.31
Net Income
$455.70 million
Pretax Margin
13.95%

Debt

Sales & Book Value

Annual Sales
$5.37 billion
Cash Flow
$7.63 per share
Price / Cash Flow
13.21
Book Value
$27.72 per share
Price / Book
3.63

Miscellaneous

Free Float
98,634,000
Market Cap
$10.15 billion
Optionable
Optionable
Beta
0.92

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NYSE:EHC) was last updated on 3/29/2025 by MarketBeat.com Staff
From Our Partners